$514 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 123 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 27.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMRN | Sell | BIOMARIN PHARMAC INC | $12,837,563 | -0.2% | 145,090 | -2.3% | 2.50% | +16.6% |
LLY | Sell | LILLY ELI & CO | $12,496,329 | +12.1% | 23,265 | -2.1% | 2.43% | +30.9% |
OPCH | Sell | OPTION CARE HEALTH | $12,147,425 | -4.1% | 375,500 | -3.7% | 2.36% | +11.9% |
PRVA | Sell | PRIVIA HEALTH GROUP | $11,376,306 | -14.0% | 494,622 | -2.4% | 2.22% | +0.5% |
Sell | R1 RCM INC | $11,215,004 | -24.9% | 744,194 | -8.0% | 2.18% | -12.3% | |
HQY | Sell | HEALTHEQUITY INC | $10,510,069 | -9.2% | 143,875 | -21.5% | 2.05% | +6.1% |
EVH | Sell | EVOLENT HEALTH INCcl a | $10,432,957 | -29.5% | 383,142 | -21.5% | 2.03% | -17.6% |
RDNT | Sell | RADNET INC | $10,405,887 | -20.0% | 369,134 | -7.4% | 2.03% | -6.5% |
ATRC | Sell | ATRICURE INC | $10,360,102 | -12.4% | 236,532 | -1.3% | 2.02% | +2.3% |
NARI | Sell | INARI MED INC | $9,028,012 | +1.5% | 138,043 | -9.8% | 1.76% | +18.5% |
JNJ | Sell | JOHNSON & JOHNSON | $8,854,388 | -13.9% | 56,850 | -8.5% | 1.72% | +0.6% |
INSM | Sell | INSMED INC | $8,771,648 | -19.7% | 347,392 | -32.9% | 1.71% | -6.3% |
UNH | Sell | UNITEDHEALTH GRP INC | $8,533,416 | -22.6% | 16,925 | -26.2% | 1.66% | -9.5% |
ICLR | Sell | ICON PLC | $8,289,514 | -30.9% | 33,663 | -29.8% | 1.61% | -19.3% |
AMGN | Sell | AMGEN INC | $7,542,749 | +20.2% | 28,065 | -0.7% | 1.47% | +40.4% |
Sell | MOONLAKE IMMUNOTHERAclass a | $5,584,005 | -40.7% | 97,965 | -46.9% | 1.09% | -30.8% | |
OLMA | Sell | OLEMA PHARMACEUTICAL | $5,405,002 | -7.7% | 437,652 | -32.5% | 1.05% | +7.9% |
ALNY | Sell | ALNYLAM PHARMACUETCL | $5,128,816 | -9.5% | 28,960 | -2.9% | 1.00% | +5.7% |
LNTH | Sell | LANTHEUS HLDGS INC | $4,932,177 | -40.4% | 70,987 | -28.1% | 0.96% | -30.5% |
PTCT | Sell | PTC THERAPEUTICS I | $4,191,029 | -55.5% | 187,016 | -19.3% | 0.82% | -48.1% |
SBTX | Sell | ARS PHARMACEUTICALS | $3,965,942 | -52.9% | 1,049,191 | -16.4% | 0.77% | -45.0% |
IQV | Sell | IQVIA HOLDINGS INC | $3,738,250 | -24.7% | 19,000 | -14.0% | 0.73% | -12.1% |
SWAV | Sell | SHOCKWAVE MEDICAL | $3,464,340 | -35.9% | 17,400 | -8.2% | 0.68% | -25.2% |
SRPT | Sell | SAREPTA THERAPEUTICS | $2,182,687 | -63.7% | 18,006 | -65.7% | 0.42% | -57.5% |
PMVP | Sell | PMV PHARMACEUTICALS | $1,865,479 | -10.3% | 303,824 | -8.6% | 0.36% | +4.6% |
EYPT | Sell | EYEPOINT PHARMA | $1,406,879 | -48.0% | 176,080 | -43.4% | 0.27% | -39.4% |
Sell | AMYLYX PHARMACEUTIC | $1,348,623 | -83.9% | 73,655 | -81.0% | 0.26% | -81.1% | |
BGNE | Sell | BEIGENE LIMITEDspn adr | $599,327 | -42.0% | 3,332 | -42.6% | 0.12% | -32.0% |
LEGN | Sell | LEGEND BIOTECH CORPspon ads | $448,024 | -18.9% | 6,670 | -16.6% | 0.09% | -5.4% |
RDY | Sell | DR REDDYS LABS LTDadr | $300,915 | -40.4% | 4,500 | -43.8% | 0.06% | -29.8% |
HZNP | Sell | HORIZON THERAPEUTICS | $290,960 | -64.2% | 2,515 | -68.2% | 0.06% | -57.8% |
APLS | Sell | APELLIS PHARMACEUTIC | $198,569 | -98.5% | 5,220 | -96.4% | 0.04% | -98.2% |
ZLAB | Sell | ZAI LAB LTDadr | $72,930 | -67.1% | 3,000 | -62.5% | 0.01% | -62.2% |
SMMT | Sell | SUMMIT THERAPEUTICS | $37,400 | -70.2% | 20,000 | -60.0% | 0.01% | -66.7% |
ARQT | Sell | ARCUTIS BIOTHERAPEUTICS | $23,136 | -83.0% | 4,357 | -69.5% | 0.01% | -78.3% |
TPST | Exit | TEMPEST THERAPEUTICS | $0 | – | -219,394 | -100.0% | -0.05% | – |
BEAM | Exit | BEAM THERAPEUTICS | $0 | – | -63,500 | -100.0% | -0.34% | – |
Exit | EQRX INC | $0 | – | -1,135,967 | -100.0% | -0.35% | – | |
SILK | Exit | SILK ROAD MEDICAL | $0 | – | -80,500 | -100.0% | -0.44% | – |
BMY | Exit | BRISTOL MYERS SQUIBB | $0 | – | -50,000 | -100.0% | -0.53% | – |
Exit | ACELYRIN INC | $0 | – | -201,017 | -100.0% | -0.70% | – | |
Exit | 2SEVENTY BIO INC | $0 | – | -462,485 | -100.0% | -0.78% | – | |
RETA | Exit | REATA PHARMACEUTICcl a | $0 | – | -47,500 | -100.0% | -0.81% | – |
GRTX | Exit | GALERA THERAPEUTIC | $0 | – | -2,005,054 | -100.0% | -1.04% | – |
TVTX | Exit | TRAVERE THERAPEUTICS | $0 | – | -435,313 | -100.0% | -1.12% | – |
AGLY | Exit | AGILITI INC | $0 | – | -469,277 | -100.0% | -1.29% | – |
INSP | Exit | INSPIRE MED SYS INC | $0 | – | -24,000 | -100.0% | -1.30% | – |
TMCI | Exit | TREACE MED CONCEPT | $0 | – | -379,443 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.